Dados B3 › GPAR3 × EGIE3
GPAR3 × EGIE3
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | GPAR3 | EGIE3 | year |
|---|---|---|---|
| ROE | 0.0%! | 21.5% | 2025 |
| ROIC | 0.0%! | 13.9% | 2025 |
| ROA | 0.0%! | 5.4% | 2025 |
| Gross margin | 53.6% | 54.4% | 2024 |
| EBIT margin | 50.8% | 68.5% | 2024 |
| Net margin | 119.8% | 38.4% | 2024 |
| Net debt/EBITDA | — | 3.30x | no year where both have it |
| Current ratio | 1.66x | 1.12x | 2025 |
| Revenue growth (1y) | -100.0%! | 14.6% | 2025 |
| Revenue growth (5y CAGR) | -31.6% | 2.7% | 2024 |
| Piotroski F-Score | 2/9! | 5/9 | 2025 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | GPAR3 | EGIE3 | year |
|---|---|---|---|
| P/E | — | 14.21x | 2025 |
| P/B | 1.35x | 2.88x | 2025 |
| EV/EBITDA | — | 8.09x | 2025 |
| FCF yield | — | 4.3% | 2025 |
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 07:30 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 07:30 UTC. If this does not match /saude, you are reading a cached copy.